Schizophrenia (SZ) is a mental disorder that typically emerges in late adolescence or early
adulthood. It reduces the life expectancy of patients by 15 years. Abnormal behavior …

Major depressive disorder (MDD: unipolar depression) is widely distributed in the USA and
world-wide populations and it is one of the leading causes of disability in both adolescents …

Background Previous studies have reported that galectin-3 is involved in inflammatory
processes in the central nervous system and that neuroinflammation may play a role in the …

It is suggested studying phenotypes within the syndrome of schizophrenia will accelerate
understanding the complex molecular pathology of the disorder. Supporting this hypothesis …

Schizophrenia is recognised as a major mental illness and is prevalent in approximately 1%
of the global population. This paper reviewed literature published between 2001 and 2013 …

We undertook an unbiased metabolite profiling of fibroblasts from schizophrenia patients
and healthy controls to identify metabolites and pathways that are dysregulated in disease …

Despite being a major cause of disability worldwide, the pathophysiology of schizophrenia
and molecular basis of treatment response heterogeneity continue to be unresolved. Recent …

Schizophrenia is a severe brain disease seen all over the world. There are studies showing
that activator of transcription and developmental regulator AUTS2 (AUTS2) gene is involved …

Artificial intelligence (AI)‐driven analysis of comprehensive clinical parameters is bringing
about a significant transformation in traditional routine clinical laboratory testing. This …

This study developed potential blood-based biomarker tests for diagnosing and
differentiating schizophrenia (SZ), bipolar disorder type I (BD), and normal control (NC) …